ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: PUB032

The PTH-Nutrition Paradox: Mild PTH Elevation Is Associated with Preserved Phase Angle and Protein Intake in Patients on Hemodialysis

Session Information

Category: Bone and Mineral Metabolism

  • 502 Bone and Mineral Metabolism: Clinical

Authors

  • Kim, Do Hyoung, Hallym University Kangnam Sacred Heart Hospital, Yeongdeungpo-gu, Seoul, Korea (the Republic of)
  • Lee, Sua, Hallym University Kangnam Sacred Heart Hospital, Yeongdeungpo-gu, Seoul, Korea (the Republic of)
  • Kim, Soh Yeon, Hallym University Kangnam Sacred Heart Hospital, Yeongdeungpo-gu, Seoul, Korea (the Republic of)
  • Kim, Eunjung, Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, Gyeonggi-do, Korea (the Republic of)
  • Choi, Gwangho, Chuncheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea (the Republic of)
  • Oh, Dong-jin, Myongji Hospital, Goyang-si, Gyeonggi-do, Korea (the Republic of)
Background

The nutritional implications of lower-target versus mildly elevated parathyroid hormone (PTH) levels in hemodialysis (HD) remain unclear. We evaluated whether mild PTH elevation was associated with nutritional and body composition measures compared with lower-target PTH over a 3-year period.

Methods

This prospective cohort study included 64 maintenance HD patients followed from 2019 to 2022. Patients were stratified by 3-year averaged intact PTH into a lower-target group (150≤PTH<300 pg/mL, n=28) and a mild-elevation group (300≤PTH<600 pg/mL, n=36). Outcomes included phase angle (PhA), creatinine-to-body surface area ratio (Cr/BSA), albumin, normalized protein catabolic rate (nPCR), and achievement of nPCR ≥1.0 g/kg/day. Longitudinal associations were assessed using linear mixed-effects models. Binary outcomes were assessed using Firth penalized logistic regression.

Results

Age and sex were similar between groups, whereas diabetes was more frequent in the lower-target group. In time-averaged analyses, the mild-elevation group had higher PhA (4.52±1.09° vs. 3.94±0.83°, P=0.017), Cr/BSA (492.7±93.9 vs. 434.4±107.3 μmol/L/m2, P=0.027), and lean tissue index (13.9±3.5 vs. 12.4±2.3 kg/m2, P=0.044). The proportion achieving nPCR ≥1.0 g/kg/day was also higher in the mild-elevation group (72.2% vs. 32.1%, P=0.002). In fully adjusted longitudinal models including age, sex, diabetes, baseline body mass index, baseline Kt/V, calcium, and phosphorus, mild PTH elevation remained associated with higher PhA (β=0.38, 95% CI 0.01–0.75; P=0.047) and nPCR (β=0.12, 95% CI 0.00–0.24; P=0.042). In fully adjusted Firth logistic regression, mild PTH elevation was independently associated with achieving nPCR ≥1.0 g/kg/day (OR 9.35, 95% CI 2.34–48.47; P=0.001).

Conclusion

Mild PTH elevation was associated with a more favorable nutritional and muscle-related phenotype than lower-target PTH in maintenance HD patients, particularly reflected by higher PhA and a greater likelihood of adequate protein intake. These findings suggest that PTH values should be interpreted together with nutritional and body composition status rather than as isolated biochemical targets.